NET-ex Evaluation of MRI of the liver in the diagnostic accuracy of extrahepatic metastases

NET-ex Evaluation of MRI of the liver in the diagnostic accuracy of extrahepatic metastases - NET-EX

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025701

Enrollment

100

Registered

2023-02-22

Start date

2021-10-11

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C78.5 C78.3

Interventions

Group 1: Cohort study: retrospective, non-randomized, monocentric, single-arm study. This study is a retrospective cohort analysis. We evaluate data from patients with neuroendocrine tumors who under

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who have MRI of the liver with liver-specific contrast agent including DWI on a 1.5T scanner and prompt (within 3 months) adjacent somatostatin receptor PET/CT by the Department and Polyclinic of Radiology and the Department of Nuclear Medicine of the University Hospital of Munich.

Exclusion criteria

Exclusion criteria: Patients who have shown artifacts on imaging.

Design outcomes

Primary

Measure	Time frame
Sensitivity, specificity, negative and positive predictive value of liver MRI (for different sequences) for extrahepatic metastases.	—

Secondary

Measure	Time frame
Demographic data (age & sex) and histopathological data of the primarius (proliferation index (ki-67) and grading (G1- G3).	—

Countries

Germany

Contacts

Public ContactMaria Ingenerf

Klinik und Poliklinik für Radiologie Klinikum der Universität München Campus Großhadern

maria.ingenerf@med.uni-muenchen.de(089) 4400-73647

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026